OccuLogix Inc.

88 articles about OccuLogix Inc.

• OccuLogix Inc. Changes Corporate Name to TearLab Corporation

  5/21/2010

• OccuLogix Inc., dba TearLab Corporation, Reports Q1-10 Financial Results

  5/11/2010

• OccuLogix Inc., dba TearLab Corporation, Reports 2009 Financial Results

  3/25/2010

• OccuLogix Inc. dba TearLab Corporation to Release Q4-09 Financial Results on March 25

  3/19/2010

• OccuLogix Inc. Announces Commitments to Purchase $5.0 Million of Company Securities in a Registered Direct Financing

  3/15/2010

• OccuLogix Inc. Release: Peer-Reviewed Article Further Validates TearLab(tm) as the Technology of Choice to Aid in the Diagnosis of Dry Eye Disease

  2/26/2010

• OccuLogix Inc. (dba TearLab Corporation) Announces Total Equity Raise of $3,000,000

  1/12/2010

• OccuLogix Inc., dba TearLab Corporation, Reports Q2-09 Financial Results

  8/12/2009

• TearLab Corporation Announces Financing Agreement

  7/16/2009

• OccuLogix Inc., dba TearLab Corporation, Reports Q1-09 Financial Results

  5/14/2009

• OccuLogix Inc. Release: TearLab(tm) Osmolarity System Wins Medical Design Excellence Award

  4/9/2009

• OccuLogix Inc., dba TearLab Corporation, Files Annual Report On Form 10-K and Report of Ernst & Young LLP

  4/7/2009

• OccuLogix Inc., dba TearLab Corporation, Reports 2008 Financial Results

  3/26/2009

• TearLab Corporation Initiates International Clinical Study of TearLab(tm) Osmolarity System

  3/11/2009

• OccuLogix Inc. Announces Change of Stock Symbols

  1/16/2009

• OccuLogix Inc. Release: Positive Data From the TearLab(TM) Osmolarity System 510K Submission Presented Today at the American Academy of Ophthalmology and European Society of Ophthalmology (SOE) 2008 Joint Meeting

  11/11/2008

• OccuLogix Inc. Reports Q3-08 Financial Results

  11/10/2008

• OccuLogix Inc. Regains Compliance With NASDAQ Continued Listing Requirements

  10/30/2008

• OccuLogix Inc. Submits 510(k) Premarket Notification for the Tearlab(TM) Osmolarity System

  10/29/2008

• OccuLogix Inc. Provides Progress Update on the Commercial Development of Its TearLab(TM) Osmolarity System

  10/15/2008